grant

Therapeutic targeting of CD40L-Mac-1 in inflammatory disease, in particular atherosclerosis [ 2010 - 2012 ]

Also known as: Therapeutic targeting of cell adhesion molecules in inflammatory disease, in particular atherosclerosis

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/586653]

Researchers: Prof Karlheinz Peter (Principal investigator)

Brief description Atherosclerosis is a major burden for human health resulting in myocardial infarction-stroke. We have previously identified a novel interaction between two adhesion molecules, CD40L and Mac-1, which mediates leukocyte adhesion to endothelial cells being a major determinant of atherosclerotic plaque development. We are now developing blocking peptides and recombinant antibodies thereby exploring various anti-inflammatory- anti-atherosclerotic strategies, targeting both Mac-1 and CD40L.

Funding Amount $AUD 559,642.56

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857